Vitamins and mineral supplements can help address nutritional deficiencies that commonly affect people who have Crohn’s ...
High blood pressure is linked to a myocardial anatomical change called LVH. Learn how to offset left ventricular thickening ...
Merck's consistent dividend payments over 34 years, healthy balance sheet, and attractive valuation highlight its investment ...
Are you a print subscriber? Activate your account. By Garett Sloane - 2 hours 35 min ago By Gillian Follett - 2 hours 35 min ago By E.J. Schultz - 2 hours 35 min ago By Jack Neff - 2 hours 35 min ...
The Gardasil franchise is the company's second largest sales driver behind Keytruda, and Merck remains steadfast it can garner more than $11 billion from the key product in 2030. Fewer than 10% of ...
(Reuters) -Merck & Co said on Thursday that weak sales of Gardasil in China are likely to carry over into 2025 as the vaccine's distributor there reduces inventories amid low demand, and the U.S ...
MERCK lowered the top end of its full-year sales guidance after demand for its HPV vaccine fell for a second straight quarter in China. Sales of the Gardasil shot, which is given to teenagers and ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Davis, chairman and chief executive officer, Merck. “Our pipeline is advancing and expanding, demonstrating our success in creating a sustainable innovation engine, and positioning Merck with a more ...
What Is Cat Scratch Fever? Cat scratch fever or cat scratch disease is an infection caused by the bacteria Bartonella henselae. You usually get this disease when an infected cat licks an open ...
Tooth pain (toothache) affects the teeth in your oral cavity (mouth). The intensity of your pain can range from a dull ache to a pulsing pain. Excruciating tooth pain can affect your daily life ...
During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...